COVID-19 Impact on Rare Disease Drug Market, Global Research Reports 2020-2021
SKU ID : QYR-15719381 | Publishing Date : 28-May-2020 | No. of pages : 105
This report provides a complete quantitative data and qualitative analysis on the global market for Rare Disease Drug. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Rare Disease Drug was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Rare Disease Drug is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Rare Disease Drug, including the following market information:
Global Rare Disease Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)
Global Rare Disease Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)
Global Rare Disease Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)
Global Rare Disease Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Doses)
Key market players
Major competitors identified in this market include Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, AstraZeneca, Eisai Co., Ltd., Daiichi Sankyo Company Limited, Bayer AG, GlaxoSmithKline, Merck & Co., Inc., Johnson & Johnson, Biogen, Inc., Takeda, Amgen, Inc., Deciphera, Atara Biotherapeutics, ProQR, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Above 1‰
0.65‰~1‰
Below 0.1‰
Based on the Application:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Prior to COVID-19, the global market for Rare Disease Drug was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Rare Disease Drug is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Rare Disease Drug, including the following market information:
Global Rare Disease Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)
Global Rare Disease Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)
Global Rare Disease Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)
Global Rare Disease Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Doses)
Key market players
Major competitors identified in this market include Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, AstraZeneca, Eisai Co., Ltd., Daiichi Sankyo Company Limited, Bayer AG, GlaxoSmithKline, Merck & Co., Inc., Johnson & Johnson, Biogen, Inc., Takeda, Amgen, Inc., Deciphera, Atara Biotherapeutics, ProQR, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Above 1‰
0.65‰~1‰
Below 0.1‰
Based on the Application:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.